Email alerts
Advanced Search
  • Apr 24, 2012
    Medtronic Named One of America's Best Corporate Citizens
    Medical Technology Leader Ranked in Top 50 on Corporate Responsibility Magazine's 100 Best Corporate Citizens List

    MINNEAPOLIS, Apr 24, 2012 (BUSINESS WIRE) --Medtronic, Inc. is one of America's best corporate citizens, according to the rankings recently released by Corporate Responsibility magazine. Medtronic...

  • Apr 17, 2012
    Medtronic Announces Global Drug-Eluting Balloon Study
    International Research Program Will Collect and Assess Safety and Efficacy Data on IN.PACT Admiral(TM) Drug-Eluting Balloon in Treatment of Peripheral Artery Disease

    MINNEAPOLIS & LONDON, Apr 17, 2012 (BUSINESS WIRE) --In conjunction with the Charing Cross International Symposium (CX34), which concludes today in London, Minneapolis-based Medtronic, Inc. (NYSE:...

  • Apr 16, 2012
    Medtronic Endurant(R) AAA Stent Graft Shows Durable Performance at Two Years in U.S. Study
    Market-Leading Medical Device for Minimally Invasive Treatment of Abdominal Aortic Aneurysms Continues to Demonstrate Strong Safety and Efficacy

    MINNEAPOLIS & LONDON, Apr 16, 2012 (BUSINESS WIRE) --Bolstering confidence in endovascular repair of abdominal aortic aneurysms (AAA), Medtronic Inc. (NYSE:MDT) announced yesterday the two-year...

  • Apr 16, 2012
    Medtronic Announces Launch of the POWEREASE(TM) System
    Latest innovation offers power technology for reconstructive spine surgery

    MEMPHIS, Tenn., Apr 16, 2012 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today announced the initiation of its launch of the POWEREASE(TM) System, an innovative system of electronic instruments...

  • Apr 13, 2012
    Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study
    First Patients Treated in Clinical Trial of Novel Medical Device Involving Interventions for Lower-Extremity Peripheral Artery Disease

    MINNEAPOLIS, Apr 13, 2012 (BUSINESS WIRE) --Expanding its commitment to developing innovative treatments for cardiovascular disease and the evidence to support their adoption, Medtronic, Inc....

Show 5102550100 per page